Attention

All comments are subject to approval by Moderators. Any off-topic comments will be rejected. Thanks for your cooperation!

Thursday, July 13, 2017

In a medical milestone decades in the making, a gene-altering leukemia therapy got a unanimous vote of confidence from an F.D.A. panel

A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight leukemia, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system to shut down the disease.

2 comments:

Anonymous said...

PRAISE THE GREAT LORD ABOVE !!!!!!!

Anonymous said...

Amen 10:34!